These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1093 related items for PubMed ID: 28260428

  • 1. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B, Canver B, Gurlek Demirci B, Colak T, Ozdemir BH, Haberal M.
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [Abstract] [Full Text] [Related]

  • 2. Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus.
    de Sandes-Freitas TV, Felipe CR, Campos ÉF, de Lima MG, Soares MF, de Franco MF, Aguiar WF, Tedesco-Silva H, Medina-Pestana JO.
    Transplantation; 2015 Nov; 99(11):2372-81. PubMed ID: 25929604
    [Abstract] [Full Text] [Related]

  • 3. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E, Cerezo I, Macias R, Villa J, Martinez C, Cubero J, Martinez R, Ferreira F, García C.
    Transplant Proc; 2011 Nov; 43(6):2187-90. PubMed ID: 21839229
    [Abstract] [Full Text] [Related]

  • 4. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
    Zachariah MS, Dwivedi AK, Yip CS, Chang SS, Gundroo A, Venuto RC, Tomaszewski J, Patel SK, Sharma R.
    Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
    [Abstract] [Full Text] [Related]

  • 5. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ, PʼNg CH, OʼConnell PJ, Chapman JR.
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant.
    Gelens MA, Steegh FM, van Hooff JP, van Suylen RJ, Nieman FH, van Heurn LW, Peutz-Kootstra CJ, Christiaans MH.
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):1010-7. PubMed ID: 22490875
    [Abstract] [Full Text] [Related]

  • 7. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK, Weir MR.
    Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
    [Abstract] [Full Text] [Related]

  • 8. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR, Ghafari A, Hajizadeh E, Kazemnejad A.
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [Abstract] [Full Text] [Related]

  • 9. Influence of Renin-Angiotensin System Blockers on Graft Function in Retrospective Analysis of Pairs of Renal Transplant Recipients From the Same Donor.
    Zakrzewska A, Tylicki L, Debska-Slizien A.
    Transplant Proc; 2018 Dec; 50(6):1838-1841. PubMed ID: 30056911
    [Abstract] [Full Text] [Related]

  • 10. T-bet-positive mononuclear cell infiltration is associated with transplant glomerulopathy and interstitial fibrosis and tubular atrophy in renal allograft recipients.
    Yadav B, Prasad N, Agrawal V, Jain M, Agarwal V, Jaiswal A, Bhadauria D, Sharma RK, Gupta A.
    Exp Clin Transplant; 2015 Apr; 13(2):145-51. PubMed ID: 25871366
    [Abstract] [Full Text] [Related]

  • 11. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
    Rivelli RF, Gonçalves RT, Leite M, Santos MA, Delgado AG, Cardoso LR, Takiya CM.
    Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
    [Abstract] [Full Text] [Related]

  • 12. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
    Shimizu T, Toma H, Hayakawa N, Shibahara R, Ishiyama R, Hayashida A, Fujimori D, Tsunoyama K, Ikezawa E, Kitajima S, Iida S, Ishida H, Tanabe K, Honda K, Koike J.
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():26-30. PubMed ID: 26972969
    [Abstract] [Full Text] [Related]

  • 13. Causes of late transplant failure in cyclosporine-treated kidney allograft recipients.
    Moroni G, Binda V, Quaglini S, Sacchi L, Raffiotta F, Cosa F, Montagnino G, Favi E, Messa P, Ponticelli C.
    Clin Exp Nephrol; 2019 Aug; 23(8):1076-1086. PubMed ID: 31016431
    [Abstract] [Full Text] [Related]

  • 14. Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols.
    Aiello FB, Furian L, Marino S, Marchini F, Cardillo M, De Fazio N, Rigotti P, Valente M.
    Int J Immunopathol Pharmacol; 2009 Aug; 22(4):1001-7. PubMed ID: 20074463
    [Abstract] [Full Text] [Related]

  • 15. Calcineurin Inhibitor-Sparing Strategies in Renal Transplantation: Where Are We? A Comprehensive Review of the Current Evidence.
    Camilleri B, Bridson JM, Halawa A.
    Exp Clin Transplant; 2016 Oct; 14(5):471-483. PubMed ID: 27213490
    [Abstract] [Full Text] [Related]

  • 16. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 17. Upregulated Expression of Circulating MicroRNAs in Kidney Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy.
    Zununi Vahed S, Poursadegh Zonouzi A, Ghanbarian H, Ghojazadeh M, Samadi N, Ardalan M.
    Iran J Kidney Dis; 2017 Jul; 11(4):309-318. PubMed ID: 28794294
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts.
    Cockfield SM, Wilson S, Campbell PM, Cantarovich M, Gangji A, Houde I, Jevnikar AM, Keough-Ryan TM, Monroy-Cuadros FM, Nickerson PW, Pâquet MR, Ramesh Prasad GV, Senécal L, Shoker A, Wolff JL, Howell J, Schwartz JJ, Rush DN.
    Am J Transplant; 2019 Jun; 19(6):1730-1744. PubMed ID: 30582281
    [Abstract] [Full Text] [Related]

  • 19. Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management.
    Zotta F, Guzzo I, Morolli F, Diomedi-Camassei F, Dello Strologo L.
    Pediatr Nephrol; 2018 Nov; 33(11):2167-2175. PubMed ID: 29980849
    [Abstract] [Full Text] [Related]

  • 20. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.